STOCK TITAN

T. Rowe Price Discloses 5.6% Stake in Becton Dickinson (16.18M Shares)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Becton, Dickinson and Co. is reported as having 16,178,519 shares beneficially owned by T. Rowe Price Investment Management, Inc., representing 5.6% of the outstanding common stock. The filing shows T. Rowe Price holds sole voting power over 15,106,743 shares and sole dispositive power over 16,178,519 shares, and classifies the filer as an investment adviser. The filing includes a written certification that the shares are held in the ordinary course of business and are not held to change or influence control of the company.

This Schedule 13G discloses a passive, greater-than-5%-ownership stake in BDX by a large institutional investment adviser, providing investors clarity on a significant passive holder and the exact voting and dispositive powers reported.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: T. Rowe Price holds a material passive stake of 5.6% in BDX with substantial sole voting and dispositive power, disclosed as passive under Schedule 13G.

The filing documents 16,178,519 shares (5.6%) beneficially owned, with 15,106,743 shares under sole voting control. As an investment adviser the filer discloses holdings and asserts these shares are held in the ordinary course and not for the purpose of changing control. For investors, this clarifies that a major institutional holder has meaningful economic exposure but claims a passive intent, which reduces immediate governance-change risk while still signaling concentrated institutional ownership.

TL;DR: A >5% passive stake by a prominent adviser is material disclosure but the filer affirms no intent to influence control.

The Schedule 13G identifies the filer as an investment adviser organized in Maryland and reports exact powers: sole voting 15,106,743 and sole dispositive 16,178,519. The certification that holdings are not intended to influence control is explicit and standard for Schedule 13G treatment. This provides transparency on ownership concentration and voting authority without indicating active engagement in corporate control actions.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



T. Rowe Price Investment Management, Inc.
Signature:Ellen York
Name/Title:Vice President
Date:08/14/2025
Becton Dickinson & Co

NYSE:BDX

View BDX Stock Overview

BDX Rankings

BDX Latest News

BDX Latest SEC Filings

BDX Stock Data

43.84B
283.55M
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
FRANKLIN LAKES